| 1 |
31630979 | Pharmacokinetic/Pharmacodynamic Relationship of Enzalutamide and Its Active Metabolite N-Desmethyl Enzalutamide in Metastatic Castration-Resistant Prostate Cancer Patients. | 2020 Apr |
2 |
| 2 |
32548867 | Phase Ib Study of Enzalutamide with or Without Sorafenib in Patients with Advanced Hepatocellular Carcinoma. | 2020 Dec |
2 |
| 3 |
30319126 | [Enzalutamide in castration resistant prostate cancer.] | 2018 Sep |
2 |
| 4 |
28280092 | A Phase I/Ib Study of Enzalutamide Alone and in Combination with Endocrine Therapies in Women with Advanced Breast Cancer. | 2017 Aug 1 |
2 |
| 5 |
28340451 | The role of drug-drug interactions in prostate cancer treatment: Focus on abiraterone acetate/prednisone and enzalutamide. | 2017 Apr |
1 |
| 6 |
26927871 | [Treatment of metastatic castration-resistant prostate cancer : Drug interaction potentials of abiraterone acetate and enzalutamide]. | 2016 Jun |
1 |
| 7 |
27604990 | Application of a "Fit for Purpose" PBPK Model to Investigate the CYP3A4 Induction Potential of Enzalutamide. | 2016 |
11 |
| 8 |
25929560 | Pharmacokinetic Drug Interaction Studies with Enzalutamide. | 2015 Oct |
4 |